Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma

Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma

Show other versions (1)

Bibliographic Details
Main Authors:	Rebecca C Abbott, Daniel J Verdon, Fiona M Gracey, Hannah E Hughes‐Parry, Melinda Iliopoulos, Katherine A Watson, Matthias Mulazzani, Kylie Luong, Colleen D’Arcy, Lucy C Sullivan, Ben R Kiefel, Ryan S Cross, Misty R Jenkins
Format:	Article
Language:	English
Published:	Wiley 2021-01-01
Series:	Clinical & Translational Immunology
Online Access:	https://doi.org/10.1002/cti2.1317

Similar Items

Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma
by: Rebecca C Abbott, et al.
Published: (2021-01-01)

Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma.
by: Ayguen Sahin, et al.
Published: (2018-01-01)

EGFRvIII: An Oncogene with Ambiguous Role
by: Adrianna Rutkowska, et al.
Published: (2019-01-01)

Development of an EGFRvIII specific recombinant antibody
by: Li Gordon, et al.
Published: (2010-10-01)

The natural history of EGFR and EGFRvIII in glioblastoma patients
by: Shi Weiming, et al.
Published: (2005-10-01)

Expression of EGFRvIII in Glioblastoma: Prognostic Significance Revisited
by: Nicola Montano, et al.
Published: (2011-12-01)

Current therapeutic advances targeting EGFR and EGFRvIII in glioblastoma
by: Emily ePadfield, et al.
Published: (2015-01-01)

GZ17-6.02 Inhibits the Growth of EGFRvIII+ Glioblastoma
by: Alphonse, M.P, et al.
Published: (2022)

GZ17-6.02 Inhibits the Growth of EGFRvIII+ Glioblastoma
by: Alphonse, M.P, et al.
Published: (2022)

Challenges in EGFRvIII detection in head and neck squamous cell carcinoma.
by: Sarah E Wheeler, et al.
Published: (2015-01-01)

Quantitative analysis of the EGFRvIII mutant receptor signaling networks in Glioblastoma
by: Huang, Hua Ming Paul
Published: (2009)

Antitumor efficacy of chimeric antigen receptor T cells against EGFRvIII-expressing glioblastoma in C57BL/6 mice
by: Muhua Chen, et al.
Published: (2019-05-01)

The biological and clinical significance of EGFR, EGFRvIII and IGF-IR in colorectal cancer
by: Cunningham, Matthew Paul
Published: (2005)

EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma.
by: Hongsheng Miao, et al.
Published: (2014-01-01)

A novel small molecule that selectively inhibits glioblastoma cells expressing EGFRvIII
by: Oberlies Nicholas H, et al.
Published: (2007-04-01)

LncRNAs and EGFRvIII sequestered in TEPs enable blood-based NSCLC diagnosis
by: Luo CL, et al.
Published: (2018-06-01)

Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies
by: Kristina Ellwanger, et al.
Published: (2017-05-01)

Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma
by: Irene Appolloni, et al.
Published: (2021-08-01)

Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme
by: Jennifer P. Newman, et al.
Published: (2017-12-01)

Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma
by: Joseph S. Durgin, et al.
Published: (2021-05-01)

Effects of Aptamer to U87-EGFRvIII Cells on the Proliferation, Radiosensitivity, and Radiotherapy of Glioblastoma Cells
by: Xingmei Zhang, et al.
Published: (2018-03-01)

Generation of fusion protein EGFRvIII-HBcAg and its anti-tumor effect in vivo
by: Zhang Ming-xin, et al.
Published: (2009-09-01)

EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment
by: Stefanie Keller, et al.
Published: (2017-06-01)

Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma
by: Maxime Fontanilles, et al.
Published: (2020-04-01)

Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells
by: Raghupathy Vengoji, et al.
Published: (2019-06-01)

Self-Assembled Nanoparticles Prepared from Low-Molecular-Weight PEI and Low-Generation PAMAM for EGFRvIII-Chimeric Antigen Receptor Gene Loading and T-Cell Transient Modification
by: Yu Q, et al.
Published: (2020-01-01)

Arming Anti-EGFRvIII CAR-T With TGFβ Trap Improves Antitumor Efficacy in Glioma Mouse Models
by: You Li, et al.
Published: (2020-08-01)

Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations
by: Vidyalakshmi Chandramohan, et al.
Published: (2019-05-01)

Point Mutations in Retargeted gD Eliminate the Sensitivity of EGFR/EGFRvIII-Targeted HSV to Key Neutralizing Antibodies
by: Ceren Tuzmen, et al.
Published: (2020-03-01)

GLP toxicology study of a fully-human T cell redirecting CD3:EGFRvIII binding immunotherapeutic bispecific antibody.
by: Patrick C Gedeon, et al.
Published: (2020-01-01)

A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity.
by: Lauren Zebertavage, et al.
Published: (2019-01-01)

EGFRvIII mediates hepatocellular carcinoma cell invasion by promoting S100 calcium binding protein A11 expression.
by: Xiaoying Luo, et al.
Published: (2013-01-01)

Engineered superparamagnetic iron oxide nanoparticles (SPIONs) for dual-modality imaging of intracranial glioblastoma via EGFRvIII targeting
by: Xianping Liu, et al.
Published: (2019-09-01)

EGFRvIII Promotes Cell Survival during Endoplasmic Reticulum Stress through a Reticulocalbin 1-Dependent Mechanism
by: Juliana Gomez, et al.
Published: (2021-03-01)

Opposing Effect of EGFRWT on EGFRvIII-Mediated NF-κB Activation with RIP1 as a Cell Death Switch
by: Vineshkumar Thidil Puliyappadamba, et al.
Published: (2013-08-01)

Pigment Epithelium-Derived Factor (PEDF) Expression Induced by EGFRvIII Promotes Self-renewal and Tumor Progression of Glioma Stem Cells.
by: Jinlong Yin, et al.
Published: (2015-05-01)

CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma
by: Bryan D. Choi, et al.
Published: (2019-11-01)

Correction: Pigment Epithelium-Derived Factor (PEDF) Expression Induced by EGFRvIII Promotes Self-renewal and Tumor Progression of Glioma Stem Cells.
by: Jinlong Yin, et al.
Published: (2016-01-01)

TNFα inhibitor C87 sensitizes EGFRvIII transfected glioblastoma cells to gefitinib by a concurrent blockade of TNFα signaling
by: Li Ma, et al.
Published: (2019-09-01)

EGFR and EGFRvIII undergo stress- and EGFR kinase inhibitor-induced mitochondrial translocalization: A potential mechanism of EGFR-driven antagonism of apoptosis
by: Ali-Osman Francis, et al.
Published: (2011-03-01)

Cannot write session to /tmp/vufind_sessions/sess_csm0h0biets7phbute845ump1k